VX-680 (MK-0457)

tozasertib · Merck Sharp & Dohme LLC

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for VX-680 (MK-0457), covering 2015-08-25 to 2015-08-25. Get the full timeline:

Most recent: Clinical Trial Update: MK0457 in Patients With Leukemia (0457-003) [Phase 1]